You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
维权投资者Elliott据报增持英国药厂葛兰素史克股份
阿思达克 04-16 10:12
英国《金融时报》报道,维权投资者Elliott Management增持英国药厂葛兰素史克的股份,总值数以十亿英镑计。葛兰素史克股价昨(15日)升4.6%报1,348.4便士,盘中曾升7.7%见1,388.4便士。

葛兰素史克2月表示,今年盈利跌幅将大过预期,受新冠疫情持续影响其他医护需求,与及增加新药投资。作为全球销售额最大疫苗生产商,葛兰素史克没有选择研发新冠疫苗,仅集中於向疫苗生产商供应材料,但公司与法国赛诺菲药厂的相关合作计划延後,与中国三叶草生物制药的协议更已完结。公司2月与德国CureVac达成协议,就下一代新冠疫苗合作。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account